Pemphigus Vulgaris Successfully Treated with Cyclophosphamide

  1. ALAN EBRINGER, M.B., M.R.A.C.P.; and
  2. IAN R. MACKAY, M.D., F.R.C.P., F.R.A.C.P.
  1. Victoria
    , Australia
  1. Requests for reprints should be addressed to Dr. Ian Mackay, The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital,
    Victoria 3050
    , Australia.

SUMMARY

A 49-year-old woman had pemphigus vulgaris for 8 years. She had been treated for 5 years with prednisolone in increasingly high doses, up to 200 mg daily, and had developed numerous and life-threatening side-effects. She was treated over the last 3 years with cyclophosphamide, 200 mg daily, in four separate courses. This allowed gradual reduction in the high maintenance doses of prednisolone and induced remissions.

Article and Author Information

  • From the Clinical Research Unit of The Walter and Eliza Hall Institute of Medical Research and The Royal Melbourne Hospital, Victoria, Australia.

  • Dr. Mackay was aided in this study by a grant from the National Health and Medical Research Council of Australia, Canberra, Australia.

    • Received December 19, 1968.
    • Accepted February 21, 1969.
« Previous | Next Article »Table of Contents